Loading clinical trials…
Loading clinical trials…
Clinical trials · failure tracking
Oncology studies whose overall status is TERMINATED, WITHDRAWN or SUSPENDED on ClinicalTrials.gov, with the stop reason exactly as the registrant posted it. A category is attached only when an explicit keyword rule matches the text; CancerIndex never infers why a study stopped.
12 stopped studies mapped to Kaposi Sarcoma and descendants · 92% state a reason
Over the 12 studies matching the cancer, status and year filters (the category filter does not change this chart). Each study is counted once, in the first matching category; greyed bars are studies whose text matched no rule or was empty.
Computedrules ci-stop-reasons-v1 · keyword matching only
A category is assigned when one of its keywords appears in the posted text (case-insensitive, whole words). Rules are tested in this order and the first match wins; every match is kept in the API (reasonMatches).
| NCT | Title | Phase | Status | First posted | Lead sponsor | Why stopped (as posted) | Category |
|---|---|---|---|---|---|---|---|
| NCT01412515 | A Phase II Study With Tumor Molecular Pharmacodynamic (MPD) Evaluation of Oral… | Phase 2 | terminated | Aug 9, 2011 | Institut National de la Santé Et de la Recherche Médicale, France | results from interim analysis conducted to study interruption | Efficacy / futility |
| NCT05846724 | Pembrolizumab Plus Lenvatinib in Previously Treated Classic Kaposi Sarcoma(PULSAR) | Phase 2 | withdrawn | May 6, 2023 | Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico | The lack of adequate funding has made it impossible to continue with the clinical study As this… | Funding |
| NCT02408861 | Nivolumab and Ipilimumab in Treating Patients With HIV Associated Relapsed or Refractory… | Phase 1 | terminated | Apr 6, 2015 | National Cancer Institute (NCI) | Inadequate accrual rate | Enrollment / accrual |
| NCT04893018 | NT-I7 for Kaposi Sarcoma in Patients With or Without HIV | Phase 1 | terminated | May 19, 2021 | Fred Hutchinson Cancer Center | Terminated due to end of funding | Funding |
| NCT00287495 | BAY 43-9006 (Sorafenib) to Treat Patients With Kaposi's Sarcoma | Phase 1 | terminated | Feb 6, 2006 | National Cancer Institute (NCI) | not stated | Not stated |
| NCT01752569 | A Study of Selumetinib in Patients With Kaposi's Sarcoma(SCART) | Phase 1 / Phase 2 | terminated | Dec 19, 2012 | Sheffield Teaching Hospitals NHS Foundation Trust | Poor recruitment | Enrollment / accrual |
| NCT00020683 | A Phase II Trial of COL-3 in Patients With HIV Related Kaposi's Sarcoma | Phase 2 | terminated | Jan 27, 2003 | National Cancer Institute (NCI) | Cancer Therapy Evaluation Program's (CTEP's) termination of drug supply | Drug supply |
| NCT00686842 | PTC299 in Treating Patients With HIV-Related Kaposi Sarcoma | Phase 1 / Phase 2 | terminated | May 30, 2008 | AIDS Malignancy Consortium | Drug supply unavailable. | Drug supply |
| NCT02229981 | Early Phase Evaluation of ABC294640 in Patients With Refractory/Relapsed Diffuse Large…(ABC-102) | Phase 1 / Phase 2 | withdrawn | Sep 3, 2014 | RedHill Biopharma Limited | Study was discontinued due to lack of recruitment. | Enrollment / accrual |
| NCT02080416 | Nelfinavir for the Treatment of Gammaherpesvirus-Related Tumors | Early Phase 1 | terminated | Mar 6, 2014 | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Very slow accrual; terminated to allow resources to be utilized more effectively on other studies.… | Enrollment / accrual |
| NCT02137564 | Gamma Secretase Inhibitor PF-03084014 in Treating Patients With AIDS-Associated Kaposi… | Phase 2 | withdrawn | May 14, 2014 | AIDS Malignancy Consortium | Drug supply unavailable | Drug supply |
| NCT00521092 | Sunitinib Malate in Treating East African Patients With Kaposi Sarcoma | Phase 2 | withdrawn | Aug 27, 2007 | National Cancer Institute (NCI) | No participants enrolled. | Enrollment / accrual |
Stop reasons are registrant-reported free text and are displayed verbatim (truncated; hover for the full text). Categories come from explicit keyword rules and are never inferred from the study design, sponsor or outcome; a study that stopped for several reasons is filed under the first rule that matched. A TERMINATED status does not imply a negative result.
Data updated 22 days agoSource updated Jun 4, 2026source: clinicaltrials